MarketInOut Stock Screener Log In | Sign Up

20/20 Biolabs Inc

NASDAQ • Healthcare • Medical Devices • Quote as of 11/20/2026
20/20 Biolabs Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2.2 mln
Float9.29 mln
Earnings Date11/16/2026

Relative Strength

19 / 100
Significantly lagging

Debt / Equity

0.18
Very low leverage

Pre-Tax Margin

-285%
Severely loss-making

ROE

-387
Deeply negative

Altman Z-Score

-9.84
Deeply distressed

ROA

-120
Deeply negative

Business Description

20/20 GeneSystems is a Maryland-based medical testing company that helps detect cancer early through blood tests and provides tools to identify viral infections like COVID-19. Beyond direct testing, it runs a shared laboratory facility where new diagnostic companies can develop and launch their products in the U.S. market. It also works with healthcare providers to deliver its cancer screening technology through a software platform.

Key Fundamentals

EPS-0.75
ROE-387
RPS0.22
ROIC-179
ROA-120
Interest Cover-7.51
EBITDA, mln-5.05
EV / EBITDA-0.03
EV / EBIT-0.03
Revenue, mln2.04
EV / Revenue0.07

Quote Details

Last 0.1571
Change -0.0235 (-13.01%)
Open 0.1802
Volume 301,482
Turnover 47,363
Average Volume 229,918

Financial Ratios

Pre-Tax Profit Margin-285
Leverage Ratio2.32
Current Ratio1.99
Price / Book1.41
Price / Tangible Book2.04
Debt / Equity0.18
Price / Sales0.99

Financial Strength

Altman Z-Score-9.84
Short Ratio0.40
Short % of Float0.50

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -23.1% 12 / 100   
1 Month -37.34% 13 / 100   
2 Months -71.45% 7 / 100   
6 Months -83.97% 6 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog